APTPUO-Winter 2027-BPS4102-A00

University of OttawaOttawa, ON
Onsite

About The Position

The University of Ottawa is seeking a Regular Part-Time Professor for the course BPS 4102 Pharmaceuticals: Federal and International Regulations during the 2027 Winter Semester in the Faculty of Science, Department of Chemistry and Biomolecular Sciences. This course focuses on Canadian and international regulations for pharmaceutical registration, submission package preparation, and the review process by Canadian regulatory agencies. The course is a lecture component and is not necessarily offered every year. The University of Ottawa is committed to diversity, inclusion, and creating a barrier-free work environment. All qualified candidates are encouraged to apply, with priority given to Canadians and permanent residents. The hiring process will be governed by the current APTPUO collective agreements.

Requirements

  • Introduction to Canadian Acts, Regulations and Guidelines pertaining to registration of agents affecting humans, animals and/or the environment.
  • Comparative information on international trends and regulations.
  • Basic knowledge for preparing submission packages in support of registration of new biopharmaceutical products.
  • Discussion on the submission review process undertaken by Canadian regulatory agencies in carrying out detailed risk assessment of new products.
  • An acceptable level of education and/or experience could be viewed as being equivalent to the educational required and/or demonstrated experience.
  • Competence in second language: Active

Nice To Haves

  • Not necessarily offered every year.

Responsibilities

  • Teach the course BPS 4102 Pharmaceuticals: Federal and International Regulations.
  • Provide instruction on Canadian Acts, Regulations and Guidelines pertaining to registration of agents affecting humans, animals and/or the environment.
  • Cover comparative information on international trends and regulations.
  • Educate on basic knowledge for preparing submission packages in support of registration of new biopharmaceutical products.
  • Discuss the submission review process undertaken by Canadian regulatory agencies in carrying out detailed risk assessment of new products.

Benefits

  • Competitive salary
  • Defined benefit pension plan
  • Group insurance coverage
  • Employee and family assistance program
© 2026 Teal Labs, Inc
Privacy PolicyTerms of Service